Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo

International Journal of Pharmaceutics

Volumn 374, Issue 1-2, 2009, Pages 114-118

  Sawant, Rupa R ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cell penetrating peptide; Intracellular drug delivery; Intratumoral drug administration; Paclitaxel; Polyethyleneglycol phosphatidylethanolamine; Polymeric micelles; TAT peptide

Indexed keywords

CELL PENETRATING PEPTIDE; MACROGOL 1000; MACROGOL 750; MACROGOL DERIVATIVE; PACLITAXEL; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; EXPERIMENTAL NEOPLASM; FEMALE; HUMAN; HUMAN CELL; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; GENE PRODUCTS, TAT; HUMANS; IN SITU NICK-END LABELING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICELLES; PACLITAXEL; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS;

EID: 67349169756     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.02.022     Document Type: Article

References (30)

1. Astriab-Fisher A., Sergueev D., Fisher M., Shaw B.R., and Juliano R.L. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19 (2002) 744-754
2. Bae Y., and Kataoka K. Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation. J. Control. Release 116 (2006) e49-e50
3. Fretz M.M., Koning G.A., Mastrobattista E., Jiskoot W., and Storm G. OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. Biochim. Biophys. Acta 1665 (2004) 48-56
4. Fujita T., Furuhata M., Hattori Y., Kawakami H., Toma K., and Maitani Y. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. J. Control. Release 129 (2008) 124-127
5. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., and Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 71 (1994) 219-225
6. Kale A.A., and Torchilin V.P. Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates. Bioconjug. Chem. 18 (2007) 363-370
7. Kale A.A., and Torchilin V.P. Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes. J. Drug Target 15 (2007) 538-545
8. Kataoka K., Harada A., and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. 47 (2001) 113-131
9. Krishnadas A., Rubinstein I., and Onyuksel H. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm. Res. 20 (2003) 297-302
10. Levchenko T.S., Rammohan R., Volodina N., and Torchilin V.P. Tat peptide-mediated intracellular delivery of liposomes. Methods Enzymol. 372 (2003) 339-349
11. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., and Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18 (2000) 410-414
12. Lukyanov A.N., and Torchilin V.P. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv. Drug Deliv. Rev. 56 (2004) 1273-1289
13. Maeda H., Bharate G.Y., and Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. (2008) 10.1016/j.ejpb.2008.11.010
14. Maeda H., Wu J., Sawa T., Matsumura Y., and Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65 (2000) 271-284
15. Nguyen J., Xie X., Neu M., Dumitrascu R., Reul R., Sitterberg J., Bakowsky U., Schermuly R., Fink L., Schmehl T., Gessler T., Seeger W., and Kissel T. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. J. Gene Med. 10 (2008) 1236-1246
16. Rao K.S., Reddy M.K., Horning J.L., and Labhasetwar V. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29 (2008) 4429-4438
17. Rothbard J.B., Jessop T.C., Lewis R.S., Murray B.A., and Wender P.A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 126 (2004) 9506-9507
18. Sawant R.R., Sawant R.M., Kale A.A., and Torchilin V.P. The architecture of ligand attachment to nanocarriers controls their specific interaction with target cells. J. Drug Target 16 (2008) 596-600
19. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
20. Sethuraman V.A., and Bae Y.H. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J. Control. Release 118 (2007) 216-224
21. Snyder E.L., and Dowdy S.F. Cell penetrating peptides in drug delivery. Pharm. Res. 21 (2004) 389-393
22. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73 (2001) 137-172
23. Torchilin V.P. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 24 (2007) 1-16
24. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., and D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1972-1977
25. Torchilin V.P., Lukyanov A.N., Gao Z., and Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6039-6044
26. Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 8786-8791
27. Vives E., Richard J.P., Rispal C., and Lebleu B. TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci. 4 (2003) 125-132
28. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
29. Zhao M., Kircher M.F., Josephson L., and Weissleder R. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 13 (2002) 840-844
30. Zorko M., and Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Deliv. Rev. 57 (2005) 529-545